Functional assessment of solid tumours and treatment strategies using MR imaging biomarkers
- Prosjektnummer
- 911383
- Ansvarlig person
- Cecilie Brekke Rygh
- Institusjon
- Universitetet i Bergen
- Prosjektkategori
- Forskerutdanning - postdoc
- Helsekategori
- Other
- Forskningsaktivitet
- 4. Detection and Diagnosis
Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.
PLoS One 2011;6(7):e23062. Epub 2011 jul 29
PMID: 21829586
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.
Proc Natl Acad Sci U S A 2011 Mar;108(9):3749-54. Epub 2011 feb 14
PMID: 21321221
Single-channel blind estimation of arterial input function and tissue impulse response in DCE-MRI.
IEEE Trans Biomed Eng 2012 Apr;59(4):1012-21. Epub 2011 des 30
PMID: 22217906
Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET.
Clin Cancer Res 2011 Feb;17(3):550-9. Epub 2010 nov 24
PMID: 21106723
Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume.
J Physiol 2010 Jan;588(Pt 2):325-39. Epub 2009 nov 30
PMID: 19948658
Longitudinal and quantitative assessment of tumor microcirculation using positron emission tomography
FEPS, Istanbul, Turkey, 2011
Measurements of vascular permeability in genetic mouse models.
FEPS, Istanbul, Turkey, 2011
Therapeutic targeting of NG2 proteoglycan with mAb and pre-armed NK cells in human GBM evaluated with DCE and DW MRI in rats.
Proc.Intl.Soc.Magn.Reson. in Medicine. Montreal, Canada, 2011
THERAPEUTIC TARGETING OF THE NG2 PROTEOGLYCAN WITH MAB 9.2.27 AND ADOPTIVELY TRANSFERRED NK CELLS LYSES HUMAN GLIOBLASTOMA MULTI
Neuro-Oncology 2010
Longitudinal investigation of permeability and distribution of macromolecules in mouse tumor development and malignant transform
EBM 2010
Longitudinal investigation of permeability and distribution of macromolecules in mouse tumor development and malignant transform
Experimental Biology 2010
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest